Literature DB >> 26283341

Conservation of the Host-Interacting Proteins Tp0750 and Pallilysin among Treponemes and Restriction of Proteolytic Capacity to Treponema pallidum.

Simon Houston1, John S Taylor2, Yavor Denchev1, Rebecca Hof1, Richard L Zuerner3, Caroline E Cameron4.   

Abstract

The spirochete Treponema pallidum subsp. pallidum is the causative agent of syphilis, a chronic, sexually transmitted infection characterized by multiple symptomatic and asymptomatic stages. Although several other species in the genus are able to cause or contribute to disease, T. pallidum differs in that it is able to rapidly disseminate via the bloodstream to tissue sites distant from the site of initial infection. It is also the only Treponema species able to cross both the blood-brain and placental barriers. Previously, the T. pallidum proteins, Tp0750 and Tp0751 (also called pallilysin), were shown to degrade host proteins central to blood coagulation and basement membrane integrity, suggesting a role for these proteins in T. pallidum dissemination and tissue invasion. In the present study, we characterized Tp0750 and Tp0751 sequence variation in a diversity of pathogenic and nonpathogenic treponemes. We also determined the proteolytic potential of the orthologs from the less invasive species Treponema denticola and Treponema phagedenis. These analyses showed high levels of sequence similarity among Tp0750 orthologs from pathogenic species. For pallilysin, lower levels of sequence conservation were observed between this protein and orthologs from other treponemes, except for the ortholog from the highly invasive rabbit venereal syphilis-causing Treponema paraluiscuniculi. In vitro host component binding and degradation assays demonstrated that pallilysin and Tp0750 orthologs from the less invasive treponemes tested were not capable of binding or degrading host proteins. The results show that pallilysin and Tp0750 host protein binding and degradative capability is positively correlated with treponemal invasiveness.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26283341      PMCID: PMC4598410          DOI: 10.1128/IAI.00643-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  SignalP 4.0: discriminating signal peptides from transmembrane regions.

Authors:  Thomas Nordahl Petersen; Søren Brunak; Gunnar von Heijne; Henrik Nielsen
Journal:  Nat Methods       Date:  2011-09-29       Impact factor: 28.547

2.  Structural insights into how the MIDAS ion stabilizes integrin binding to an RGD peptide under force.

Authors:  David Craig; Mu Gao; Klaus Schulten; Viola Vogel
Journal:  Structure       Date:  2004-11       Impact factor: 5.006

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

5.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

6.  Quantitative analysis of tpr gene expression in Treponema pallidum isolates: Differences among isolates and correlation with T-cell responsiveness in experimental syphilis.

Authors:  Lorenzo Giacani; Barbara Molini; Charmie Godornes; Lynn Barrett; Wesley Van Voorhis; Arturo Centurion-Lara; Sheila A Lukehart
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

7.  Purification and characterization of an enzyme produced by Treponema denticola capable of hydrolyzing synthetic trypsin substrates.

Authors:  K Ohta; K K Makinen; W J Loesche
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

8.  Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751.

Authors:  Simon Houston; Rebecca Hof; Teresa Francescutti; Aaron Hawkes; Martin J Boulanger; Caroline E Cameron
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

9.  A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin.

Authors:  Mary Beth Brinkman; Melanie A McGill; Jonas Pettersson; Arthur Rogers; Petra Matejková; David Smajs; George M Weinstock; Steven J Norris; Timothy Palzkill
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

10.  Complete genome sequence of Treponema paraluiscuniculi, strain Cuniculi A: the loss of infectivity to humans is associated with genome decay.

Authors:  David Šmajs; Marie Zobaníková; Michal Strouhal; Darina Čejková; Shannon Dugan-Rocha; Petra Pospíšilová; Steven J Norris; Tom Albert; Xiang Qin; Kym Hallsworth-Pepin; Christian Buhay; Donna M Muzny; Lei Chen; Richard A Gibbs; George M Weinstock
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

View more
  9 in total

Review 1.  Vaccine development for syphilis.

Authors:  Karen V Lithgow; Caroline E Cameron
Journal:  Expert Rev Vaccines       Date:  2016-07-18       Impact factor: 5.217

2.  Tp0684, Tp0750, and Tp0792 Recombinant Proteins as Antigens for the Serodiagnosis of Syphilis.

Authors:  Júlio Henrique Ferreira de Sá Queiroz; Marcelo Dos Santos Barbosa; Lais Gonçalves Ortolani Miranda; Natasha Rodrigues de Oliveira; Odir Antônio Dellagostin; Silvana Beutinger Marchioro; Simone Simionatto
Journal:  Indian J Microbiol       Date:  2022-04-19

Review 3.  The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.

Authors:  Sami L Gottlieb; Carolyn D Deal; Birgitte Giersing; Helen Rees; Gail Bolan; Christine Johnston; Peter Timms; Scott D Gray-Owen; Ann E Jerse; Caroline E Cameron; Vasee S Moorthy; James Kiarie; Nathalie Broutet
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

4.  A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.

Authors:  Karen V Lithgow; Rebecca Hof; Charmaine Wetherell; Drew Phillips; Simon Houston; Caroline E Cameron
Journal:  Nat Commun       Date:  2017-02-01       Impact factor: 14.919

5.  Development of real-time PCR and loop-mediated isothermal amplification (LAMP) assays for the differential detection of digital dermatitis associated treponemes.

Authors:  Kelly Anklam; Megan Kulow; Wataru Yamazaki; Dörte Döpfer
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

6.  Identification of Tp0751 (Pallilysin) as a Treponema pallidum Vascular Adhesin by Heterologous Expression in the Lyme disease Spirochete.

Authors:  Wei-Chien Andrew Kao; Helena Pětrošová; Rhodaba Ebady; Karen V Lithgow; Pablo Rojas; Yang Zhang; Yae-Eun Kim; Yae-Ram Kim; Tanya Odisho; Nupur Gupta; Annette Moter; Caroline E Cameron; Tara J Moriarty
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

7.  Dissecting the molecular diversity and commonality of bovine and human treponemes identifies key survival and adhesion mechanisms.

Authors:  Gareth J Staton; Simon R Clegg; Stuart Ainsworth; Stuart Armstrong; Stuart D Carter; Alan D Radford; Alistair Darby; Jonathan Wastling; Neil Hall; Nicholas J Evans
Journal:  PLoS Pathog       Date:  2021-03-29       Impact factor: 6.823

Review 8.  Future prospects for new vaccines against sexually transmitted infections.

Authors:  Sami L Gottlieb; Christine Johnston
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

9.  Identification of the Neuroinvasive Pathogen Host Target, LamR, as an Endothelial Receptor for the Treponema pallidum Adhesin Tp0751.

Authors:  Karen V Lithgow; Brigette Church; Alloysius Gomez; Emily Tsao; Simon Houston; Leigh Anne Swayne; Caroline E Cameron
Journal:  mSphere       Date:  2020-04-01       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.